Sayris Capital

Sayris Capital does not publicly detail its sourcing model, but the backgrounds of its principals suggest a reliance on cross-border relationships and networks in Southeast Asia. The firm's stated focus on the Global South and areas such as LNG contracting, agri-tech, and traditional medicine implies origination through direct engagement with project developers and regional partners. No external reporting confirms proprietary deal flow.

The firm's website references private equity, project financing, and commodity trading activities, but does not specify whether capital is deployed as direct equity, fund commitments, or co-investments. No publicly available portfolio list or fund structure documentation clarifies the investment vehicles used.

The firm outlines five core verticals: connectivity and tech infrastructure (including AI and data centers), renewable energy, healthcare (specifically Traditional Chinese Medicine, Ayurveda, and stem-cell research), agriculture and foodtech, and broader sustainability-linked commodity trading. These are presented as areas where the firm believes growth and sustainability can be "seamlessly integrated" (per the firm's website).

Sayris Capital states a mission to "uplift the Global South" and identifies Southeast Asia as a particular priority region for its sustainable development work. The firm does not publish a breakdown of invested capital by geography, and no specific country allocations are verifiable from public records.

Investment leadership sits with Managing Director and founder Daniel Rajesh, who is described as the firm's dealmaker for energy, food security, and technology, and co-founder Haryanto Soemito, who leads focus areas in agriculture, healthcare, and energy transition. Partners Michael Huang and Darren Ho contribute expertise in energy negotiation and sustainable agriculture, respectively. The firm does not disclose an investment committee structure.